James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 8,300 shares at $46.66 ($383K) on 2021-04-19, disclosed to the SEC on 2021-04-21.
Open-market sale of $383k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.13 | 4,000 | $185K | 48.1% |
| 2 | $46.66 | 1,300 | $61K | 15.8% |
| 3 | $46.66 | 1,300 | $61K | 15.8% |
| 4 | $45.60 | 1,700 | $78K | 20.2% |
| Total | $46.19 avg | 8,300 | $383K | 100% |
| Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |
| DCPH | SELL | 2020-07-13 | $2.6M | — | Filing → |